@article{101018, keywords = {Haematology (incl blood transfusion), Medical education, tropical medicine (infectious disease)}, author = {Mufarrih S and Lusby H and Watson P}, title = {Haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in a patient with leprosy.}, abstract = {

Multidrug therapy has significantly reduced the global burden of Hansen's disease; however, complications from long-term treatment persist. A male resident of southern Kentucky, in his 30s and of Micronesian descent, presented with worsening abdominal pain associated with anorexia, fatigue, functional decline and occasional haemoptysis. He was compliant with multidrug therapy for leprosy. Laboratory investigations revealed pancytopenia. He was initially treated under a sepsis protocol and later switched to high-dose steroids due to a suspected immune reaction from missed corticosteroid doses. Despite aggressive treatment for refractory pancytopenia, the patient's condition deteriorated, and he passed away from cardiac arrest. Posthumous bone marrow biopsy revealed haemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis with bone marrow infiltration. This case highlights the importance of proactive fungal screening in immunocompromised leprosy patients, particularly in endemic regions, as early detection and timely intervention can prevent severe complications.

}, year = {2024}, journal = {BMJ case reports}, volume = {17}, month = {09/2024}, issn = {1757-790X}, doi = {10.1136/bcr-2024-262041}, language = {ENG}, }